The average direct cost for hospital treatment for patients with COVID-19 in the United States rose by 26% from 2020 to 2022; scientists have developed a new type of antibiotic to treat a deadly bacteria resistant to most current antibiotics; a survey conducted for Utah state officials gave some clues as to why millions of Americans lost Medicaid coverage last year.
Scientists at MIT and McMaster University have utilised artificial intelligence (AI) to identify a new antibiotic with the potential to combat drug-resistant infections caused by Acinetobacter baumannii, a bacterium commonly found in hospital settings.
Using AI, researchers identified a new antibiotic that can kill Acinetobacter baumannii, a type of bacteria that is responsible for many drug-resistant infections.